DRUG · COUNSELLING NOTES
Tralokinumab
Adtralza®
Updated
New prescription
indication: _____. SC q2wk; refrigerate, do not shake; warned on allergies; serious/common AEs: injection-site reaction, conjunctivitis, cold symptoms; non-pharm: daily emollients, avoid triggers.
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; SC q2wk; refrigerate, do not shake; warned on allergies; serious/common AEs: injection-site reaction, conjunctivitis, cold symptoms; non-pharm: daily emollients, avoid triggers.